Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled trial evaluated safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Cerebral Ischemia
• Delayed Ischemic Neurological Deficit
• Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Kwong Wah Hospital | Conditions: Subarachnoid Hemorrhage, Intracranial Aneurysm | Phase 2, Phase 3 | Status: COMPLETED